在复发性星细胞瘤中评估CDKN2A状态的临床实用性
Hemlata Jangir1, Sahil Yadav2, M B Hayagrivas2
1Neuropathology Laboratory, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.
Brain tumor pathology
|March 13, 2025
概括
在IDH突变天体细胞瘤中评估CDKN2A删除是至关重要的. 同胞性CDKN2A删除,特别是在复发性瘤中,表明存活率较差,有助于个性化治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 分子病理学分子病理学
- 癌症基因组学 癌症基因组学
背景情况:
- IDH突变天体细胞瘤显示出比IDH野生型更有利的预后.
- 世卫组织2021年分类强调CDKN2A/B同卵性缺失作为天体细胞瘤的关键分级标准.
- 缺乏对FISH测定结果在质瘤预后中的标准化解释指南.
研究的目的:
- 为了研究CDKN2A在IDH突变天体细胞瘤中的同卵性缺失的预后意义.
- 评估FISH试验对于检测初级和复发性星系细胞瘤中CDKN2A缺失的有用性.
- 建议优化FISH测试策略,以改善患者分层.
主要方法:
- 一项对22例IDH突变天体细胞瘤病例的宏观研究,包括初级和复发性瘤.
- 组织病理学评估,世卫组织分类和分子分析.
- 针对IDH突变状态的免疫组织化学和针对CDKN2A同胞性缺失的FISH分析.
主要成果:
- 同胞性CDKN2A删除在原发性瘤中罕见 (4.8%,3级),但在复发性瘤中明显更频繁 (35.3%,2/3级).
- 患有CDKN2A删除的患者的整体存活率显著降低.
- CDKN2A删除状态是IDH突变天体细胞瘤复发的显著预后标志物.
结论:
- 对复发的IDH突变天体细胞瘤,CDKN2A评估具有临床意义.
- 鱼类检测应选择性地应用于初级3级和所有复发性星系细胞瘤.
- 这种方法提高了诊断的准确性,并有助于个性化治疗策略.
更多相关视频
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.4K
06:53Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
8.6K
相关概念视频
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K